Joined May 2020
- Tweets 20
- Following 77
- Followers 154
- Likes 63
2 Photos and videos
aMoon retweeted
11 Aug 2021
Congrats to the Zebra Medical Vision Ltd team as they merge with Nanox Vision to form an innovative Israeli #radiology company combining cutting edge hardware, software and #artificialintelligence. lnkd.in/ddbGzzgy
2
1
5
aMoon retweeted
11 May 2021
Congrats to Robert Habib, Nagi Habib and the superb team at MiNA Therapeutics for the recent deal signed with Eli Lilly and Company š
aMoon Fund, Gur Roshwalb Omri Strul Tamar Farfel-Becker lnkd.in/dwH6azg
1
3
aMoon retweeted
24 Mar 2021
With the close of our Series C financing, we will use proceeds to expand commercial efforts for our patient molecular signature test, PrismRAĀ®, and data partnerships with payers, providers, and pharma. sciphermedicine.com/scipher-ā¦
6
6
20
9 Mar 2021
Congratulations to our partners at @IbexMedAx on raising a $38 million Series B financing, embarking on a new chapter in their journey to transform cancer diagnosis & pathology by harnessing #AI #technology at an unprecedented scale.
techcrunch.com/2021/03/09/ibā¦
1
2
aMoon retweeted
9 Mar 2021
Proud to announce $38 million Series B, led by @OctopusVentures and @83Northvc. We embark on a new chapter in our journey to transform #cancer diagnosis by harnessing AI at an unprecedented scale. Read more ibex-ai.com/press/round-b-anā¦ @DellTechCapital @aMoonFund #digitalpathology
2
6
15
8 Mar 2021
On #InternationalWomensDay we celebrate the amazing talent, dedication & achievements of the women of aMoon!
We are proud & inspired by your commitment and ambition to accelerate cure!
12 Jan 2021
The #HealthTech industry has much to look forward to in 2021!
Tomer Berkovitz, our Partner & CFO on this āindustry #revolutionā and some major events in our portfolio including Seerās #IPO.
bloomberg.com/news/articles/ā¦
1
1
12 Jan 2021
Congratulations to Biolojic Design, Ltd. and Apple Tree Partners on the spin out and launch of Aulus - the novel breakthrough in #AI computationally designed anti-bodies IL-2.
endpts.com/michael-ehlers-isā¦
1
6 Jan 2021
What's dawning on HealthTechās horizon in 2021?
The rise of omics is transforming #LifeSciences Tools & Diagnostics from a sleepy segment to a booming industry that cuts across the #healthcare value chain and is revolutionizing delivery of #patientcare.
bit.ly/3rZvnwU
2
3
3 Jan 2021
"It's about touching and improving lives".
Our Partner Moshe Mor spoke with @TheMarker about his recent move from #tech to #healthtech & the $100M raise for our early-stage Velocity Fund. @YSchindel
themarker.com/technation/.prā¦
1
1
aMoon retweeted
1 Oct 2020
SOPHiA GENETICS - incredible company, exceptional leadership! Jurgi Camblong & Troy Cox - On behalf of myself, Tomer Berkovitz and the entire aMoon Fund team, weāre honored to partner with you to help accelerate genomics globally for the benefit of patienā¦lnkd.in/gzRu9Vf
3
8
aMoon retweeted
30 Sep 2020
ā#Alexa, do I have #COVID19?ā Vocalis Health CEO Tal Wenderow speaks with @Nature on how vocal #biomarkers can help clinicians address the COVID-19 pandemic by triaging potential cases and identifying people who might be most in need of testing. Read more: nature.com/articles/d41586-0ā¦
4
4
aMoon retweeted
4 Sep 2020
Incredible to see MDClone & Intermountain Healthcare collaborating: (1) Saving lives and reducing morbidity for #chronickidneydisease patients (2) Identifying and engaging CKD patients to enable 86% avoidance in unplanned admissioā¦lnkd.in/du9pntd lnkd.in/dJNpd7p
1
2
aMoon retweeted
8 Jul 2020
In pandemic era, entrepreneurs turn to SPACs, crowdfunding and direct listings tcrn.ch/2ZUjpr0 by @jshieber
10
20
21 May 2020
aMoon retweeted
18 May 2020
I am proud to announce that Zebra Medical Vision has received its fifth FDA (510k) clearance for our vertebral compression fractures (VCF) product. businesswire.com/news/home/2ā¦
2
6 May 2020
Our Managing Partner @YSchindel, a member of Israel's MOH task force on #COVID19, spoke to the @nytimes about the pandemic & #Israelās latest serology initiative to determine the prevalence of antibodies to COVID-19.
6 May 2020
Israel will begin conducting over the coming weeks a major effort to determine the prevalence of antibodies to Covid-19 by testing 100,000 people nyti.ms/3bc9pgu